# IRADIMED CORP (IRMD) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from IRADIMED CORP's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/IRMD/mda/fy2025/): filed 2026-03-06; accession 0001104659-26-024691 (https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/IRMD/mda/fy2024/): filed 2025-03-06; accession 0001558370-25-002389 (https://www.sec.gov/Archives/edgar/data/1325618/000155837025002389/irmd-20241231x10k.htm)
- [FY 2023 MD&A](/company/IRMD/mda/fy2023/): filed 2024-03-01; accession 0001558370-24-002235 (https://www.sec.gov/Archives/edgar/data/1325618/000155837024002235/irmd-20231231x10k.htm)
- [FY 2022 MD&A](/company/IRMD/mda/fy2022/): filed 2023-03-02; accession 0001104659-23-028003 (https://www.sec.gov/Archives/edgar/data/1325618/000110465923028003/irmd-20221231x10k.htm)
- [FY 2021 MD&A](/company/IRMD/mda/fy2021/): filed 2022-03-04; accession 0001104659-22-030317 (https://www.sec.gov/Archives/edgar/data/1325618/000110465922030317/irmd-20211231x10k.htm)

Back to /company/IRMD/